Kathy Deuchars

Dr. Kathy Deuchars is Special Projects Manager at Ontario Genomics Institute (Private Equity).
Dr. Deuchars was previously employed as Senior Investment Analyst by MDS Capital Corp.
Previously She was President and CEO of Attodyne Inc., a start-up medical/industrial device company based on technology from the University of Toronto.
Before that Dr. Deuchars was Chief Operating Officer of University Medical Discoveries and MedInnova Partners, technology development corporations that focused on the development and commercialization of early-stage biomedical innovations.
She joined UMDI/MedInnova in 2000 and garnered experience at all stages of the investment process including acting on the boards of several companies.
Previously, Dr. Deuchars spent 6 years in the biotechnology industrial sector as a research scientist at NPS Allelix Inc., where she supported or led various drug discovery programs.
Dr. Deuchars earned her Ph.D.
from the Ontario Cancer Institute, The University of Toronto, in the area of the molecular biology of cancer chemotherapy resistance.